跳至主要内容
临床试验/NCT01453842
NCT01453842已完成早期 1 期

Diet Oil Induced Stimulation of GLP-1

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2011年3月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
12
试验地点
2
主要终点
Plasma GLP-1

研究概览

简要总结

Activation of G protein-coupled receptor GPR119 stimulates glucagon-like peptide-1 (GLP-1)release from the intestinal L-cells. Previously, administration of 2-oleyl-glycerol (2-OG) to humans significantly increased plasma GLP-1. In the present study we want to test the effect in patients with type 2 diabetes. The hypothesis is that we will expect to find a significant increased plasma GLP-1 following a meal containing of 2-OG when compared to meals containing of olive oil or carbohydrates alone.

详细描述

Activation of G protein-coupled receptor GPR119 stimulates glucagon-like peptide-1 (GLP-1)release from the intestinal L-cells. Previously, administration of 2-oleyl-glycerol (2-OG) to humans significantly increased plasma GLP-1. In the present study we want to test the effect in patients with type 2 diabetes. The hypothesis is that we will expect to find a significant increased plasma GLP-1 following a meal containing of 2-OG when compared to meals containing of olive oil or carbohydrates alone. The aim of the study is to elucidate the effect of 2-OG, 'diet oil' on GLP-1 secretion in patients with type 2 diabetes and to explain the mechanism behind the known stimulation of GLP-1 release by dietary fat.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with type 2 diabetes mellitus according to the WHO criteria
  • caucasians
  • age above 18 years
  • BMI 20-30

排除标准

  • kidney disease
  • liver disease
  • retinopathy
  • use of insulin
  • use of GLP-1 analogues
  • use of DPP-4 inhibitors

结局指标

主要结局

Plasma GLP-1

时间窗: 3 hours

Glp-1 response is measured during and three hours after ingestion of the different mealtest

次要结局

  • Plasma insulin(3 hours)
  • Plasma glucose(3 hours)
  • Plasma GIP(3 hours)
  • Plasma glucagon(3 hours)
  • Plasma PYY(3 hours)
  • Plasma paracetamol(3 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Katrine Bagge Hansen

MD

University of Copenhagen

研究点 (2)

Loading locations...

相似试验